Adenosine receptors: pharmacology, structure-activity relationships, and therapeutic potential
- 1 February 1992
- journal article
- review article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 35 (3) , 407-422
Abstract
No abstract availableKeywords
This publication has 131 references indexed in Scilit:
- Pentoxifylline does not act via adenosine receptors in the inhibition of the superoxide anion production of human polymorphonuclear leukocytesBiochemical and Biophysical Research Communications, 1991
- 2-Aralkoxyadenosines: potent and selective agonists at the coronary artery A2 adenosine receptorJournal of Medicinal Chemistry, 1991
- Cardiovascular actions of adenosines, but not adenosine receptors, differ in rat and guinea pigLife Sciences, 1991
- Purine Nucleosides and Nucleotides as Central Nervous System ModulatorsAnnals of the New York Academy of Sciences, 1990
- Inhibition of nucleoside uptake in human erythrocytes by a new series of compounds related to lidoflazine and mioflazineEuropean Journal of Pharmacology: Molecular Pharmacology, 1990
- RDC8 codes for an adenosine A2 receptor with physiological constitutive activityBiochemical and Biophysical Research Communications, 1990
- Structure-activity relationships of 8-cycloalkyl-1,3-dipropylxanthines as antagonists of adenosine receptorsJournal of Medicinal Chemistry, 1990
- Inhibition of nucleoside transport by a new series of compounds related to lidoflazine and mioflazineEuropean Journal of Pharmacology: Molecular Pharmacology, 1989
- An Investigation of the Low Intrinsic Activity of Adenosine and Its Analogs at Low Affinity (A2) Adenosine Receptors in Rat Cerebral CortexJournal of Neurochemistry, 1986
- Specific photoaffinity labelling of inhibitory adenosine receptorsBiochemical and Biophysical Research Communications, 1985